Yonsei University: Carcinoma, Hepatocellular trials

The registry lists 16 Carcinoma, Hepatocellular studies with Yonsei University as lead sponsor. 6 are open to participants now and 0 have results posted.

Phase 2 6Phase 3 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Single-arm Phase II Clinical Study Investigating the Safety and Efficacy of Carbon Ion Radiotherapy in Patients With Hepatocellular Carcinoma Previously Treated With Transarterial Radioembolization (TARE)RecruitingNCT07252323Not applicable
• A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular CarcinomaRecruitingNCT07246668Phase 2
• Adjuvant Everolimus in High-Risk Hepatocellular Carcinoma After Curative Resection (SEVERANCE Trial)Not yet recruitingNCT06972758Phase 2
• Atezolizumab and BEvacizumab With STereotactic Body Radiotherapy for Advanced Hepatocellular CarcinomaRecruitingNCT06595108Not applicable
• Effects of Cognitive Intervention Therapy on Postoperative DeliriumNot yet recruitingNCT06178939Not applicable
• Atezolizumab and Bevacizumab With Combined Radiotherapy for Advanced Hepatocellular CarcinomaNot yet recruitingNCT05908916Phase 2
• Gemcitabine With Oxaliplatin (GEMOX) in Patients With Advanced Hepatocellular Carcinoma After Failure of Sorafenib TreatmentCompletedNCT05517239Phase 2
• Stereotactic Ablative Radiotherapy for Oligometastatic Hepatocellular CarcinomaStatus unknownNCT05173610Phase 2
• Hepatocyte-specific Versus Extracellular Contrast Agents for Liver MRI: Prospective, Intra-individual Comparison of Diagnostic Performance for Hepatocellular CarcinomaStatus unknownNCT03892681Not applicable
• Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver TransplantationCompletedNCT03490461
• Usefulness of Non-contrast MagnetIc Resonance imAging Versus Non-Contrast Ultrasonography for surveiLlancE of HepatoCellular Carcinoma [MIRACLE-HCC]Status unknownNCT02514434Not applicable
• Efficacy of Localized Concurrent Chemo-radiation Therapy and Sorafenib Sequential Therapy in Advanced Hepatocellular CarcinomaCompletedNCT02425605Phase 2
• Contrast (Sonazoid)-Enhanced US as a Screening Tool for Hepatocellular Carcinoma in Cirrhosis: An Exploratory Cross-sectional StudyCompletedNCT02188901Not applicable
• Noninvasive Surrogate Marker for Advanced Hepatocellular Carcinoma Response to Concurrent Chemoradiotherapy: MR Perfusion, Contrast Enhanced Ultrasound and BiomarkersStatus unknownNCT01336452Not applicable
• Study of PIVKA-II and AFP Measurement in Surveillance Program for Early Detection of Hepatocellular CarcinomaStatus unknownNCT01277653
• Adjuvant Hepatic Arterial Infusional Chemotherapy After Curative Resection of Hepatocellular CarcinomaCompletedNCT01088581Phase 3